Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
Polygiene Group AB
F:44P
|
SE |
|
T
|
Tutor Perini Corp
F:PE2
|
US |
|
B
|
Barclays PLC
DUS:BCY
|
UK |
|
Covivio SA
F:F5D
|
FR |
|
C
|
China Merchants Bank Co Ltd
SWB:M4B
|
CN |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
FirstRand Ltd
F:FSRA
|
ZA |
|
B
|
Brady Corp
F:BRV
|
US |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
MIL:BBVA
|
ES |
Intrinsic Value
The intrinsic value for
Akebia Therapeutics Inc (AX9) under the Base Case is hidden
EUR.
Compared with the current market price of 1.07 EUR, the stock appears hidden
.
AX9 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if AX9 is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Akebia Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Akebia Therapeutics Inc
Earnings Waterfall
Akebia Therapeutics Inc
The intrinsic value for
Akebia Therapeutics Inc (AX9) under the Base Case is hidden EUR.
Compared with the current market price of 1.07 EUR, the stock appears hidden.